feed,title,long_url,short_url
Motley,Could This Biosimilar Drug Candidate Be a Winner for Amgen?,https://www.fool.com/investing/2022/09/09/could-this-biosimilar-drug-be-a-winner-for-amgen/?source=iedfolrf0000001,https://bit.ly/3ROPY35
Motley,Here's Why Shares of SelectQuote Are Exploding Higher This Week,https://www.fool.com/investing/2022/09/09/why-selectquote-slqt-stock-is-higher-this-week/?source=iedfolrf0000001,https://bit.ly/3qp69Z5
